Abbott Laboratories
ABT· NYSE
Abbott Laboratories
- Last sale
- Oct 2, 2026 · +0.82%
- Market cap
- $168.70B
- 1.73B shares
- Filings
- 1,062
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $44,328,000,000 | reported | |
| FY 2024 | 2024-12-31 | $41,950,000,000 | reported | |
| FY 2023 | 2023-12-31 | $40,109,000,000 | reported | |
| FY 2022 | 2022-12-31 | $43,653,000,000 | reported | |
| FY 2021 | 2021-12-31 | $43,075,000,000 | reported | |
| FY 2020 | 2020-12-31 | $34,608,000,000 | reported | |
| FY 2019 | 2019-12-31 | $31,904,000,000 | reported | |
| FY 2018 | 2018-12-31 | $30,578,000,000 | reported | |
| FY 2017 | 2017-12-31 | $27,390,000,000 | reported | |
| FY 2016 | 2016-12-31 | $20,853,000,000 | reported | |
| FY 2015 | 2015-12-31 | $20,405,000,000 | reported | |
| FY 2014 | 2014-12-31 | $20,247,000,000 | reported |
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
